HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1963581Generated: October 30, 2026
Hydrochloric Acid → HCID 131730475, compound
https://huagongshe.com/reaction/1963581
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Hydroxylamine | HCID 787 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | HCID 131730473 | HCID 131730473 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 131730475 | HCID 131730475 | 96% |
Reaction Steps
Trans-methyl 4-(3-ethoxy-3-oxopropanoyl)-2-(4-(trifluoromethoxy)benzyl)piperidine-1-carboxylate (679 mg, 1.57 mmol) (from example 113, step 1) was dissolved in MeOH (10 mL) and cooled to −40° C. under nitrogen. Sodium hydroxide (0.463 mL, 1.57 mmol) dissolved in water (1.000 mL) was added during 10 min and the yellow solution continued to stir at −40° C. for 20 min. Hydroxylamine (50% by weight in water, 0.096 mL, 1.57 mmol) was added during 8 min. The resulting solution was stirred at −40° C. for 3 h 15 min. The mixture was then rapidly poured into a prewarmed (80° C.) solution of 6 M hydrogen chloride (8.11 mL, 48.63 mmol) and the mixture continued to stir at 80° C. for 20 min. The solvent was evaporated and DCM/water added. The phases were separated and the organic phase passed through a phase separator and evaporated to yield a white solid. Crude trans-methyl 4-(3-oxo-2,3-dihydroisoxazol-5-yl)-2-(4-(trifluoromethoxy)benzyl)piperidine-1-carboxylate (603 mg, 96%) was isolated. MS m/z 401 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08415378B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-02f72c3c5e614db2bfd1548159852721 |
|---|
| Source note | uspto-grants-2013_04 |
|---|